Finding 1241236 (2024-003)

Material Weakness Repeat Finding
Requirement
C
Questioned Costs
-
Year
2024
Accepted
2026-10-27
Audit: 415344
Organization: Black Womens Health Imperative (DC)

AI Summary

  • Core Issue: There is a significant deficiency in internal controls related to cash drawdowns for the Diabetes Control Programs.
  • Impacted Requirements: Compliance with 2 CFR Part 200.303 and 2 CFR Part 200.305 is not being met, as there was no review of cash drawdowns totaling $1,114,944.
  • Recommended Follow-Up: Implement and document adequate internal controls for the cash drawdown process to ensure accuracy and compliance.

Finding Text

Finding 2024-003 Finding Type: Significant deficiency in internal control Federal Department: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention Identification of the Federal Program: Assistance Listing Number 93.988 – Cooperative Agreements for Diabetes Control Programs Award Number: NU58DP007394 Compliance Requirement(s): Cash Management Criteria: Under 2 CFR Part 200.303 (Internal Controls) and 2 CFR Part 200.305 (Federal Payment Standards), non-federal entities must maintain internal controls that provide reasonable assurances that drawdowns are accurate, reviewed, and aligned with actual immediate cash needs. Condition: For all five cash drawdowns performed during 2024 totaling $1,114,944, we noted no evidence of review prior to submission in the Payment Management Services (PMS) system. Cause: This finding occurred due to oversight and inadequate procedures. Effect: The potential exists for general ledger expenditures to not align with drawn-down funds. Questioned Costs: None. Repeat Finding: Not applicable. Recommendation: We recommend that the Imperative implement procedures to establish, document, and maintain adequate internal controls over the cash drawdown process. View of Responsible Officials: See management’s corrective action plan.

Corrective Action Plan

Audit Finding Number 2024-003 Audit Finding Title Cash Management Planned Corrective Action Effective September 2026, each drawdown will be prepared by Kim Cockerham, Sr. Director of Finance and Accounting and then reviewed by a separate employee before submission. Preparation and review are time stamped and documented in the CDC payment system. Name(s) and title(s) of contact person(s) responsible for corrective action Kim Cockerham, Sr. Director of Finance and Accounting

Categories

Cash Management Internal Control / Segregation of Duties Significant Deficiency Matching / Level of Effort / Earmarking

Other Findings in this Audit

  • 1241235 2024-002
    Material Weakness Repeat
  • 1241237 2024-004
    Material Weakness Repeat
  • 1241238 2024-005
    Material Weakness Repeat
  • 1241239 2024-006
    Material Weakness Repeat

Programs in Audit

ALN Program Name Expenditures
93.988 COOPERATIVE AGREEMENTS FOR DIABETES CONTROL PROGRAMS $1.26M